NRAS MUTATION CODON 12 13 and 61 Test
Welcome to DNA Labs UAE, a leading genetic lab specializing in molecular diagnostics. We offer the NRAS MUTATION CODON 12 13 and 61 Test to provide valuable insights into various cancers.
Test Details
The NRAS mutation test is a genetic test that analyzes specific regions of the NRAS gene for mutations in codons 12, 13, and 61. These mutations are known to be associated with various cancers, including melanoma, colorectal cancer, and hematological malignancies.
Test Components
- Price: 1450.0 AED
- Sample Condition: Submit formalin fixed paraffin embedded tissue block. Ship at room temperature. Block should have at least 10% tumor tissue.
- Duly filled NGS Test Requisition Form is mandatory.
Report Delivery
Sample should be submitted by Tuesday at 11 am. The report will be delivered on the following Monday.
Method
The NRAS MUTATION CODON 12 13 and 61 Test is performed using PCR and sequencing techniques.
Test Type
The NRAS MUTATION CODON 12 13 and 61 Test falls under the category of cancer tests.
Doctor
This test is typically ordered by an oncologist.
Test Department
This test is conducted in our Molecular Diagnostics department.
Pre Test Information
A duly filled NGS Test Requisition Form is mandatory for this test.
Importance of NRAS Mutation Test
The NRAS mutation test can help guide treatment decisions for individuals with specific NRAS mutations. Certain targeted therapies may be more effective for patients with these mutations. For example, individuals with NRAS mutations in codons 12 and 13 may benefit from MEK inhibitors, while those with mutations in codon 61 may respond better to other targeted therapies.
It is important to note that the NRAS mutation test should be ordered by a healthcare provider and performed in a specialized laboratory. The results of the test should be interpreted by a qualified healthcare professional who can provide appropriate guidance and treatment recommendations based on the specific mutation identified.
| Test Name | NRAS MUTATION CODON 12 13 and 61 Test |
|---|---|
| Components | |
| Price | 1450.0 AED |
| Sample Condition | Submit formalin fixed paraffin embedded tissue block. Ship at room temperature. Block should have at least 10% tumor tissue. Duly filled NGS Test Requisition Formis mandatory. |
| Report Delivery | SampleTue by 11 am; Report Mon |
| Method | PCR, Sequencing |
| Test type | Cancer |
| Doctor | Oncologist |
| Test Department: | MOLECULAR DIAGNOSTICS |
| Pre Test Information | Duly filled NGS Test Requisition Formis mandatory. |
| Test Details | The NRAS mutation test is a genetic test that analyzes specific regions of the NRAS gene for mutations in codons 12, 13, and 61. These mutations are known to be associated with various cancers, including melanoma, colorectal cancer, and hematological malignancies. The test is typically performed on a sample of tumor tissue or blood. It uses techniques such as polymerase chain reaction (PCR) and DNA sequencing to identify any mutations in the NRAS gene. The results of the NRAS mutation test can help guide treatment decisions, as certain targeted therapies may be more effective for patients with specific NRAS mutations. For example, individuals with NRAS mutations in codons 12 and 13 may benefit from MEK inhibitors, while those with mutations in codon 61 may respond better to other targeted therapies. It is important to note that the NRAS mutation test is typically ordered by a healthcare provider and performed in a specialized laboratory. The results should be interpreted by a qualified healthcare professional who can provide appropriate guidance and treatment recommendations based on the specific mutation identified. |
